Botulinum toxin A versus bupivacaine trigger point injections for the treatment of myofascial pain syndrome: A randomised double blind crossover study

Pain

Volumn 118, Issue 1-2, 2005, Pages 170-175

  Graboski, Corrie L ^a   Shaun Gray, D ^a   Burnham, Robert S ^a,b  

^a GLENROSE REHABILITATION HOSPITAL   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Botulinum toxin; Myofascial pain syndrome; Trigger point injection

Indexed keywords

BOTULINUM TOXIN A; BUPIVACAINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLD LIMB; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CROSSOVER PROCEDURE; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG COST; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; INJECTION SITE; MALE; MOVEMENT THERAPY; MUSCLE STRETCHING; MUSCLE WEAKNESS; MYOFASCIAL PAIN; NAUSEA; NOCICEPTION; PAIN ASSESSMENT; PARESTHESIA; PATIENT MONITORING; PATIENT SATISFACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; SORE THROAT; STATIC EXERCISE;

ANESTHETICS, LOCAL; BOTULINUM TOXIN TYPE A; BUPIVACAINE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG COSTS; FACIAL PAIN; FEMALE; HEALTH CARE COSTS; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; MUSCLE, SKELETAL; PAIN MEASUREMENT; PHYSICAL EXAMINATION; PHYSICAL MEDICINE; TREATMENT OUTCOME;

EID: 27644439096     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2005.08.012     Document Type: Article

References (25)

1. S.J. Atlsas, R.A. Deyo, and R.B. Keller The Maine Lumbar Spine Study, part III: 1-year outcomes of surgical and nonsurgical management of lumbar spinal stenosis Spine 21 1996 1787 1795
2. A. Chatman, S. Hyams, J. Neel, J. Binkley, P. Stratford, and A. Schomberg The patient specific functional scale: measurement properties in patients with knee dysfunction Phys Ther 77 1997 820 829
3. W. Cheshire, S. Abashian, and D. Mann Botulinum toxin in the treatment of myofascial pain syndrome Pain 59 1994 65 69
4. M.K. Childers, D.J. Wilson, J.F. Galate, and B.K. Smith Treatment of painful muscle syndromes with botulinum toxin. A review J Back Musculoskeletal Rehabil 10 1998 89 96
5. J. Cohen Statistical power analysis for the behavioral sciences 2nd ed 1988 Lawrence Erlbaum Associates Publisher Hillsdale, NJ p. 54-63
6. L.H. Daltroy, W.L. Cats-Baril, and R.B. Katz The North American Spine Society lumbar spine outcome assessment instrument: reliability and validity tests Spine 21 1996 741 749
7. R.A. Deyo, M.B. Battie, and A.J.H.M Beurskens Outcome measures for low back pain research: a proposal for standardized use Spine 23 1998 2003 2013
8. L. Foster, L. Clapp, M. Erickson, and B. Jabbari Botulinum toxin A and chronic low back pain. A randomized double-blind study Neurology 56 2001 1290 1293
9. B. Freund, and M. Schwartz Treatment of whiplash associated with neck pain with botulinum toxin A: a pilot study J Rheumatol 27 2000 481 484
10. M. Hallet How does botulinum toxin work? Ann Neurol 48 2000 7 8
11. D.R. Hubbard, and G.M. Berkoff Myofascial trigger points show spontaneous needle EMG activity Spine 18 1993 1803 1807
12. A. Kamanli, A. Kaya, O. Ardicoglu, S. Ozgocmen, F.O. Zengin, and Y. Bay Comparison of lidocaine injection, botulinum toxin, and dry needing to trigger points in myofascial pain syndrome Rhematol Int 2004 [serial online, 2004 September 15:, 15 screens] http://springerlink.metapress.com
13. A. Lang A pilot study of botulinum toxin type A (BTX A) administered using a novel injection technique for the treatment of myofascial pain Am J Pain Manage 10 2000 108 112
14. A.M. Lang Botulinum toxin type a therapy in chronic pain disorders Arch Phys Med Rehabil 84 Suppl. 1 2003 S69 S73
15. G. O'Sullivan, N. Mohammed, P. Foran, G. Lawrence, and J. Dolly Rescue of exocytosis in botulinum toxin A-poisoned chromaffin cells by expression of cleavage-resistant SNAP-25 J Biol Chem 274 1999 36897 36904
16. M.A. Porta A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm Pain 85 2000 101 105
17. M. Royal Botulinum toxins in pain management Phys Med Rehabil Clin N Am 14 2003 805 820
18. L. Satkunam Rehabilitation medicine 3. Management of adult spasticity Can Med Assoc J 169 2003 1173 1179
19. J. Smith, J. Audette, and M. Royal Botulinum toxin in pain management of soft tissue syndromes Clin J Pain 18 Suppl. 2002 147 154
20. P. Stratford, C. Gill, M. Westaway, and J. Binkley Assessing disability and change on individual patients: a report of a patient specific measure Physiother Can 47 1995 258 263
21. J.G. Travel, and S.H. Rinzler The myofascial genesis of pain Postgrad Med 11 1952 425 434
22. M. Westaway, P. Stratford, and J. Binkley The patient specific functional scale: validation of its use in persons with neck dysfunction J Orthop Sports Phys Ther 27 1998 331 338
23. A. Wheeler, P. Goolkasian, and S. Gretz A randomized double-blind prospective pilot study of botulinum toxin injection for refractory, unilateral, cervicothoracic paraspinals myofascial pain syndrome Spine 23 1998 1662 1667
24. A. Wheeler, P. Goolkasian, and S. Gretz Botulinum toxin A for the treatment of chronic neck pain Pain 94 2001 255 260
25. W. Zink, C. Seif, J. Bohl, N. Hacke, P. Bruan, B. Sinner, E. Martin, R. Rink, and B. Graf The acute myotoxic effects of bupivacaine and ropivacaine after continuous peripheral nerve blockades Anesth Analg 97 2003 1173 1179